After binding to HER2 and internalization, the linker is cleaved and the membrane-permeable payload is released, allowing diffusion into adjacent tumor cells with very low or undetectable HER2 expression and generating a “bystander effect” (11). The gene discussed is ERBB2; the disease is neoplasm.